化合物及び使用方法

Japanese Patent JP7073384

B2

The present invention provides compounds useful in treating or preventing inflammation, acne, bacterial conditions and promoting the appearance of healthy skin and compositions including these compounds.

JPS5488211	DERIVATIVE OF 4-METHYL-3-ALLYL-3-PENTEN-2-ONE AND ITS PREPARATION
WO/1999/059965	A PROCESS FOR PRODUCING AN ORGANIC TRISULFIDE COMPOUND
JP7322885	Novel allyl compound and composition for optical materials

Boronkov, Michael
Perez, edward
Healy, Jason
Fernandez, Jose

JP2019538231A

May 23, 2022

January 12, 2018

Click for automatic bibliography generation  

Signum Biosciences, Incorporated

C07C321/18; A61K31/198; A61K31/20; A61K31/397; A61K31/401; A61K31/44; A61K31/445; A61K31/4453; A61K31/4965; A61K31/505; A61K38/05; A61P29/00; C07D205/04; C07D207/16; C07D211/60; C07D211/62; C07D213/80; C07D239/42; C07D239/48; C07D241/28; C07D295/205; C07K5/072

JP2019524807A
JP2012508265A
JP2013510877A
JP2011514332A
JP2011505384A
JP2012515721A

Registry(STN)[online],2016年11月28日,CAS登録番号 2040473-30-9
Registry(STN)[online],2016年11月28日,CAS登録番号 2040473-29-6
Registry(STN)[online],2016年11月28日,CAS登録番号 2040469-40-5
Registry(STN)[online],2016年11月28日,CAS登録番号 2040469-39-2
FERNANDEZ, J. R. et al.,N-Acetylglutaminoyl-S-farnesyl-L-cysteine (SIG-1191): an antiinflammatory molecule that increases the expression of the aquaglyceroporin, aquaporin-3, in human keratinocytes,Archives of Dermatological Research,2017年,Vol.309,pp.103-110,DOI:10.1007/s00403-016-1708-x

Fukami patent office

Previous Patent: RLC layer status report Control PDU transmission method and related equipment

Next Patent: Bicyclic bis-heteroaryl derivative as a modulator of protein aggregation